Published in Biochim Biophys Acta on January 03, 2005
The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. J Neurosci Res (2009) 1.65
MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. Hum Mol Genet (2012) 1.58
The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's disease. J Neurosci (2012) 1.50
Tuning microtubule-based transport through filamentous MAPs: the problem of dynein. Traffic (2008) 1.29
Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport. Neurobiol Aging (2011) 1.04
The proline-rich domain of tau plays a role in interactions with actin. BMC Cell Biol (2009) 1.01
Altered subcellular distribution of c-Abl in Alzheimer's disease. J Alzheimers Dis (2009) 0.99
Tyrosine kinase inhibition increases functional parkin-Beclin-1 interaction and enhances amyloid clearance and cognitive performance. EMBO Mol Med (2013) 0.96
Tau splicing and the intricacies of dementia. J Cell Physiol (2012) 0.94
Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes. J Hepatol (2007) 0.92
Intermediate filament-associated cytolinker plectin 1c destabilizes microtubules in keratinocytes. Mol Biol Cell (2013) 0.90
Intracellular amyloid precursor protein sorting and amyloid-β secretion are regulated by Src-mediated phosphorylation of Mint2. J Neurosci (2012) 0.89
Connecting cell-cycle activation to neurodegeneration in Drosophila. Biochim Biophys Acta (2006) 0.87
Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease. J Biomed Biotechnol (2006) 0.86
Microtubule-mediated Src tyrosine kinase trafficking in neuronal growth cones. Mol Biol Cell (2008) 0.86
Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy. J Clin Cell Immunol (2014) 0.83
New age of neuroproteomics in Alzheimer's disease research. Cell Mol Neurobiol (2009) 0.81
Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies? Oxid Med Cell Longev (2015) 0.80
Extracellular Membrane Vesicles as Vehicles for Brain Cell-to-Cell Interactions in Physiological as well as Pathological Conditions. Biomed Res Int (2015) 0.80
Roles of tau protein in health and disease. Acta Neuropathol (2017) 0.80
Tau phosphorylation regulates the interaction between BIN1's SH3 domain and Tau's proline-rich domain. Acta Neuropathol Commun (2015) 0.78
Saitohin, which is nested within the tau gene, interacts with tau and Abl and its human-specific allele influences Abl phosphorylation. J Cell Biochem (2011) 0.76
Electrochemical investigations into kinase-catalyzed transformations of tau protein. ACS Chem Neurosci (2013) 0.76
Nuclear Tau and Its Potential Role in Alzheimer's Disease. Biomolecules (2016) 0.76
Effects of microtubule-associated protein tau expression on neural stem cell migration after spinal cord injury. Neural Regen Res (2016) 0.75
Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer's disease pathology. J Neural Transm (Vienna) (2014) 0.75